Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | TLR7 | Q9NYK1 | 7/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.44 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9443092 | 0.81 | PPARG (0.68) | PPARGAGTR1AGTR2 | |
| SCHEMBL9844285 | 0.80 | AGTR1 (0.46) | PPARGTLR7AGTR1AGTR2CYP19A1 | |
| SCHEMBL27528971 | 0.80 | PPARG (0.55) | PPARGAGTR1AGTR2 | |
| SCHEMBL9843787 | 0.79 | PDE4A (0.44) | PPARGAGTR1AGTR2CYP19A1 | |
| SCHEMBL9847780 | 0.78 | PPARG (0.56) | PPARGAGTR1AGTR2CYP19A1 | |
| SCHEMBL9847764 | 0.78 | PPARG (0.55) | PPARGAGTR1AGTR2CYP19A1 | |
| SCHEMBL9638129 | 0.78 | PPARG (0.57) | PPARGAGTR1AGTR2 | |
| SCHEMBL9844019 | 0.78 | PPARG (0.43) | PPARGAGTR1AGTR2CYP19A1 | |
| SCHEMBL9843965 | 0.77 | CYP19A1 (0.46) | PPARGAGTR1AGTR2CYP19A1 | |
| SCHEMBL27771395 | 0.77 | AGTR1 (0.61) | PPARGAGTR1AGTR2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6037349-A | HAVING ANTAGONISTIC PROPERTIES TOWARDS ANGIOTENSIN II CAN BE USED FOR THE TREATMENT OF HYPERTENSION, ALDOSTERONISM AND CARDIAC INSUFFICIENCY | MERCK PATENT GMBH (DE) | 2000-03-14 | — | — | US | disclosed |